Dudediligence.

Damora Therapeutics, Inc

DMRANASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$249,120

2 notices · 9,415 sh

Oct 2025 to Oct 2026

Reported ·

$23,308

3 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 3 reported sales carry the 10b5-1 box. Together they are under 0.01% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-05: Firmani Lori, Form 1442026-06-22: Firmani Lori, Form 1442026-01-02: Firmani Lori, sold2026-01-02: Winslow Garrett, sold2026-01-02: Schambye Hans T., sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-08-05Firmani Lori, Chief Financial Officer$55,980
1,800 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-22Firmani Lori, Chief Financial Officer$193,140
7,615 shno plan dateForm 4s on file end Jun 23144 ↗